Alcohol Use Disorder Clinical Trials in Los Angeles, California

5 studies are recruiting for alcohol use disorder in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   UCLA Clinical & Translational Research Center (CTRC), Los Angeles, California

   Locations

   118 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219966 on ClinicalTrials.gov

2. A Study of Brenipatide in Participants With Alcohol Use Disorder

   The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   UCLA Clinical & Translational Research Center (CTRC), Los Angeles, California

   Locations

   116 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219953 on ClinicalTrials.gov

3. Motivation for IV Alcohol Self-Administration in Humans

   The goal of this translational study is to understand different reasons why people between the ages of 21 and 65 with alcohol use disorder are motivated to self-administer alcohol. The main questions it aims to answer are: * How does a person's desire for a reward affect their motivation to self-ad…

   Stage

   Phase 2

   Ages

   21 to 65

   Site

   University of California, Los Angeles, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT06494891 on ClinicalTrials.gov

4. Human Laboratory Study of Apremilast for Alcohol Use Disorder

   Primary: The primary objective of this study is to compare the efficacy of two different maintenance doses of apremilast (tablets) in reducing alcohol craving among subjects with moderate to severe alcohol use disorder (AUD) after two weeks of daily dosing. Secondary: Secondary objectives include e…

   Stage

   Phase 2

   Ages

   21 and older

   Site

   University of California, Los Angeles, California

   Locations

   3 in total

   Run by

   National Institute on Alcohol Abuse and Alcoholism (NIAAA)

   See if you can join NCT07325266 on ClinicalTrials.gov

5. Tirzepatide for Alcohol Use Disorder

   The objective of this Phase 2 randomized controlled trial is to evaluate the effects of weekly tirzepatide (vs. placebo) on alcohol consumption and cardiometabolic outcomes in adults with alcohol use disorder and overweight or obesity.

   Stage

   Phase 2

   Ages

   21 to 65

   Site

   Keck School of Medicine, University of Southern California, Los Angeles, California

   Run by

   University of Southern California

   See if you can join NCT06994338 on ClinicalTrials.gov